Patrick C. Roche, SVP Research & Development at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 5,929 shares at $2.49 ($14K) on 2016-03-10, disclosed to the SEC on 2016-03-14.
Scheduled sale ($14k) by SVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.49 | 1,298 | $3K | 22.9% |
| 2 | $2.36 | 4,520 | $11K | 75.4% |
| 3 | $2.19 | 111 | $243 | 1.7% |
| Total | $2.39 avg | 5,929 | $14K | 100% |
| Filing → |